| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 225 |
| 1 | METHOTREXATE SODIUM | 54 |
| 2 | METHOTREXATE | 51 |
| 3 | RISANKIZUMAB-RZAA | 33 |
| 4 | PREDNISONE | 27 |
| 5 | UPADACITINIB | 27 |
| 6 | INFLIXIMAB | 26 |
| 7 | ERGOCALCIFEROL | 25 |
| 8 | FOLIC ACID | 25 |
| 9 | OMEPRAZOLE MAGNESIUM | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORETIGENE NEPARVOVEC-RZYL | 2 | 0.0132 |
| 1 | BALANCED SALT SOLUTION | 9 | 0.0070 |
| 2 | CEFTAZIDIME, AVIBACTAM | 1 | 0.0059 |
| 3 | BALANCED SALT SOLUTION ENRICHED WITH BICARBONATE, DEXTROSE, AND GLUTATHIONE | 2 | 0.0054 |
| 4 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 5 | DONOR HUMAN STOOL | 1 | 0.0043 |
| 6 | PROPARACAINE HYDROCHLORIDE | 2 | 0.0037 |
| 7 | ODEVIXIBAT | 1 | 0.0025 |
| 8 | BROMFENAC SODIUM | 3 | 0.0021 |
| 9 | INFLIXIMAB-DYYB | 7 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 59 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 52 |
| 2 | Corticosteroid [EPC] | 49 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 4 | Interleukin-23 Antagonist [EPC] | 40 |
| 5 | Janus Kinase Inhibitor [EPC] | 30 |
| 6 | Vitamin C [EPC] | 29 |
| 7 | Provitamin D2 Compound [EPC] | 25 |
| 8 | Vitamin B12 [EPC] | 25 |
| 9 | Vitamin D [EPC] | 25 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Ileal Bile Acid Transporter Inhibitor [EPC] | 1 | 0.0022 |
| 2 | Serotonin-4 Receptor Agonist [EPC] | 1 | 0.0015 |
| 3 | Thyroid Stimulating Hormone [EPC] | 1 | 0.0010 |
| 4 | Semifluorinated Alkane [EPC] | 2 | 0.0009 |
| 5 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 7 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Antisense Oligonucleotide [EPC] | 5 | 0.0004 |
| 9 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |